SOLIGENIX, INC. (SNGX) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $12 million, SOLIGENIX, INC. is a micro-cap company. The stock currently trades at $1.16, down 1.38% today, with a 52-week range of $1.02–$6.23.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-4.98 | $-4.98 | -530.4% | |
| 2023 | $-0.79 | $-0.79 | +83.6% | |
| 2022 | $-4.81 | $-4.81 | -1451.6% | |
| 2021 | $-0.31 | $-0.31 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | $-1.16 | $-1.16 | +13.4% | |
| 2016 | $-1.34 | $-0.93 | -346.7% | |
| 2015 | $-0.30 | $-0.30 | +30.2% | |
| 2014 | $-0.43 | $-0.32 | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-21 | 0001558370-25-003459 | SEC ↗ |
| 2023-12-31 | 2024-03-15 | 0001558370-24-003402 | SEC ↗ |
| 2022-12-31 | 2023-03-31 | 0001558370-23-005304 | SEC ↗ |
| 2021-12-31 | 2022-03-29 | 0001558370-22-004605 | SEC ↗ |
| 2020-12-31 | 2021-03-30 | 0001213900-21-018698 | SEC ↗ |
| 2019-12-31 | 2020-03-30 | 0001213900-20-007959 | SEC ↗ |
| 2018-12-31 | 2019-03-26 | 0001213900-19-004865 | SEC ↗ |
| 2017-12-31 | 2018-03-15 | 0001213900-18-003007 | SEC ↗ |
| 2016-12-31 | 2017-03-27 | 0001213900-17-002845 | SEC ↗ |
| 2015-12-31 | 2016-03-24 | 0001213900-16-011833 | SEC ↗ |
| 2014-12-31 | 2015-03-25 | 0001213900-15-002035 | SEC ↗ |
| 2013-12-31 | 2014-03-26 | 0001213900-14-001738 | SEC ↗ |
| 2012-12-31 | 2013-02-26 | 0001213900-13-000871 | SEC ↗ |
| 2011-12-31 | 2012-03-27 | 0001213900-12-001317 | SEC ↗ |
| 2010-12-31 | 2011-03-30 | 0001213900-11-001567 | SEC ↗ |
| 2009-12-31 | 2010-03-31 | 0001213900-10-001169 | SEC ↗ |
| 2008-12-31 | 2009-03-30 | 0000812796-09-000018 | SEC ↗ |